Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPYD | Q12882 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | UPP1 | Q16831 | 1/20 | 0.31 |
| ▸ | IDH1 | O75874 | 1/20 | 0.30 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.30 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.30 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10933269 | 0.80 | DAO (0.40) | DPYDMEN1KMT2AUPP1 | |
| Water SCHEMBL7070154 | 0.78 | IDH1 (0.41) | DPYDIDH1CSNK2A2CSNK2BCSNK2A1 | |
| Water SCHEMBL27941642 | 0.73 | IDH1 (0.39) | DPYDIDH1CSNK2A2CSNK2BCSNK2A1 | |
| Water SCHEMBL28334606 | 0.73 | IDH1 (0.39) | DPYDIDH1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL30107638 | 0.73 | — | — | |
| SCHEMBL16167222 | 0.71 | MEN1 (0.41) | DPYDMEN1KMT2A | |
| SCHEMBL1977724 | 0.69 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1 | |
| Hydrochloric Acid SCHEMBL546607 | 0.69 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL9402152 | 0.69 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1 | |
| SCHEMBL28045341 | 0.69 | IDH1 (0.41) | IDH1CSNK2A2CSNK2BCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HYDRO-QUéBEC (CA) | 2024-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12018000-B2 | Lithium salts of cyano-substituted imidazole for lithium ion batteries | HCN2, HCN3, HLCS | DPYD 1286/4885MEN1 1916/4885KMT2A 2126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.